UNITE4TB – Academia and Industry United Innovation and Treatment for Tuberculosis

New clinical trial design for tuberculosis drugs

As with many bacterial diseases, tuberculosis has been hit by drug resistance, threatening the efficacy of existing treatments. Although there are new drugs for clinical evaluation, testing the different combinations is time-consuming and requires a concerted effort. The EU-funded UNITE4TB project brings together experts in the field to design and set new standards for tuberculosis Phase II clinical trials. The team will take advantage of existing networks across continents to recruit patients in trials and introduce state-of-the-art microbiology methods and machine learning technologies. Data on biomarkers and clinical pharmacology will accompany the validation of the new drugs to ensure their subsequent success down the drug discovery pipeline.

Details

Status:

Supported by BayFOR:

Research Focus:

  • Medicine and Health

Countries:

Germany (Bavaria), South Africa

Funding Agency:

European Union (EU)

URL: